Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Amgen, Inc. (AMGN) vs Modine Manufacturing Company (MOD) Price & Performance

Amgen, Inc.
Modine Manufacturing Company

Price performance

Price movement over the last 24 hours

Key statistics

Amgen, Inc. vs Modine Manufacturing Company — how do they compare? Amgen, Inc. trades at $363.49 (market cap $196.12B), while Modine Manufacturing Company trades at $241.24 (market cap $12.99B). The key difference: Amgen, Inc. is far larger — about 15.1× Modine Manufacturing Company's market cap, and Amgen, Inc. pays a 2.77% dividend while Modine Manufacturing Company pays none. Which is the better fit depends on your goals.

AMGNMOD
Market Cap
$196.12B$12.99B
Sector
HealthTechnology
52-Week High
$388.16$306.89
52-Week Low
$271.18$90.02
Enterprise Value
$241.41B$13.35B
Dividend Yield
2.77%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Amgen, Inc.

AMGN trades at $363.39, down slightly by 0.06% today, with a bullish technical signal from moving averages. The company reported strong Q1 2026 earnings, beating estimates with EPS of $5.15 versus $4.77 expected. Revenue grew to $36.75B in 2025, with a net income margin of 20.96%. Recent news includes a favorable court ruling blocking a price cap on Enbrel in Colorado, but regulatory challenges persist for Tavneos in Europe.

The outlook remains positive due to consistent earnings beats and a diversified product portfolio, though risks include regulatory setbacks and competitive pressures. Analyst consensus is bullish with a 57.9% buy rating and a price target of $357.38, slightly below the current price, indicating potential for stability with upside from pipeline developments.

Modine Manufacturing Company

Modine (MOD) trades at $245.91, up 0.99% on the day, with a bearish technical signal despite recent earnings beats. The company reported strong revenue growth to $2.58 billion in 2025, though net income margin compressed to 3.82%. Analyst consensus remains bullish with a $328.80 price target, supported by 10 buy ratings. Recent news highlights Modine's positioning in the AI data center cooling market, with sales projected to grow 60-80% in fiscal 2027.

The outlook is mixed: robust growth in data center demand offers upside, but high valuation multiples (P/E 108.81) and margin pressures pose risks. Investors face volatility from supply chain challenges and competitive threats in the HVAC segment. Wall Street optimism contrasts with technical weakness, suggesting cautious optimism for long-term growth despite near-term headwinds.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Amgen, Inc.

Amgen is a leader in biotechnology-based human therapeutics, with historical expertise in renal disease and cancer supportive-care products. Flagship drugs include red blood cell boosters Epogen and Aranesp, immune system boosters Neupogen and Neulasta, and Enbrel and Otezla for inflammatory diseases. Amgen introduced its first cancer therapeutic, Vectibix, in 2006 and markets bone-strengthening drug Prolia/Xgeva (approved 2010) and Evenity (2019). The acquisition of Onyx bolstered the firm's therapeutic oncology portfolio with Kyprolis. Recent launches include Repatha (cholesterol-lowering), Aimovig (migraine), Lumakras (lung cancer), and Tezspire (asthma). Amgen's biosimilar portfolio includes Mvasi (biosimilar Avastin), Kanjinti (biosimilar Herceptin), and Amgevita (biosimilar Humira).

Read more on AMGN

About Modine Manufacturing Company

Modine Manufacturing Company is a global leader in thermal management technology and solutions. The company engineers, manufactures, and markets heat transfer products for a wide range of applications across the automotive, commercial, industrial, and HVAC (heating, ventilation, and air conditioning) markets. Modine's products include engine cooling systems, heat exchangers, and ventilation systems, providing critical thermal solutions for vehicles, data centers, and various equipment worldwide.

Read more on MOD